ストックスクリーナーアプリを入手
32.99
5.84%
1.82
アフターアワーズ：
32.99
前日終値:
$31.17
開ける：
$30.95
24時間の取引高:
219.80K
Relative Volume:
0.58
時価総額：
$1.65B
収益：
$345.60M
当期純損益:
$-79.01M
株価収益率:
-25.73
EPS:
-1.2822
ネットキャッシュフロー:
$-18.62M
1週間 パフォーマンス:
+0.86%
1か月 パフォーマンス:
+6.04%
6か月 パフォーマンス:
-45.23%
1年 パフォーマンス:
-32.88%
1日の値動き範囲:
$30.12
$33.00
1週間の範囲:
$30.12
$33.72
52週間の値動き範囲:
$29.72
$76.98
Immunocore Holdings Plc Adr Stock (IMCR) Company Profile
名前
Immunocore Holdings Plc Adr
セクター
電話
01235 5430281
住所
90 PARK DRIVE, OXFORDSHIRE
Immunocore Holdings Plc Adr Stock (IMCR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-11-20 | 再開されました | JP Morgan | Overweight |
| 2023-11-02 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-10-31 | 開始されました | Robert W. Baird | Outperform |
| 2023-09-13 | アップグレード | JP Morgan | Neutral → Overweight |
| 2023-09-13 | 開始されました | Needham | Buy |
| 2023-08-16 | 開始されました | CapitalOne | Overweight |
| 2023-07-17 | 開始されました | Canaccord Genuity | Hold |
| 2023-03-31 | 開始されました | Mizuho | Buy |
| 2023-03-30 | 開始されました | Guggenheim | Buy |
| 2023-03-24 | 開始されました | Bryan Garnier | Buy |
| 2022-12-16 | アップグレード | Goldman | Neutral → Buy |
| 2022-11-30 | 開始されました | Barclays | Overweight |
| 2022-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2022-09-08 | 開始されました | Ladenburg Thalmann | Buy |
| 2022-08-08 | 開始されました | Cowen | Outperform |
| 2022-08-02 | 開始されました | BTIG Research | Buy |
| 2022-02-08 | 開始されました | H.C. Wainwright | Buy |
| 2021-10-20 | 開始されました | Oppenheimer | Outperform |
| 2021-03-02 | 開始されました | Goldman | Neutral |
| 2021-03-02 | 開始されました | JP Morgan | Overweight |
| 2021-03-02 | 開始されました | Jefferies | Buy |
すべてを表示
Immunocore Holdings Plc Adr (IMCR) 最新ニュース
Immunocore (IMCR) Upgraded to Buy: Here's Why - Yahoo Finance
Immunocore stock hits 52-week low at $29.72 amid market challenges - Investing.com
Immunocore's SWOT analysis: biotech stock poised for growth amid clinical trials - Investing.com UK
Financial Fitness Check: Examining Immunocore Holdings plc ADR (IMCR)’s Key Ratios - The Dwinnex
Immunocore stock hits 52-week low at $32.07 amid market challenges - Investing.com
TD Cowen maintains Buy rating on Immunocore shares on ovarian cancer drug data - Investing.com India
Quarterly Metrics: Quick and Current Ratios for Immunocore Holdings plc ADR (IMCR) - The Dwinnex
Immunocore Holdings plc ADR (IMCR) is looking forward to a strong quarter - SETE News
Immunocore stock hits 52-week low at $32.84 amid market challenges - Investing.com
Ratios Revealed: Decoding Immunocore Holdings plc ADR (IMCR)’s Financial Health - The Dwinnex
Have you been able to find a good deal on Immunocore Holdings plc ADR’s shares? - US Post News
Immunocore Holdings plc (IMCR): Top ADR Stock According to Hedge Funds - Yahoo Finance UK
The growth track for Immunocore Holdings plc ADR (IMCR) has changed recently - SETE News
The Potential Rise in the Price of Sun Communities, Inc. (SUI) following insiders activity - Knox Daily
Insider Sale Alert: Terns Pharmaceuticals Inc [TERN] – Is it Time to sell? - Knox Daily
Immunocore Holdings plc ADR (IMCR) may enjoy gains as insiders got busy in the recent days - Knox Daily
Monitoring Brookline Bancorp, Inc. (BRKL) after recent insider movements - Knox Daily
Immunocore Holdings plc ADR [IMCR] Shares Fall -4.18% on Thursday - Knox Daily
Financial Health Report: Immunocore Holdings plc ADR (IMCR)’s Ratios Tell a Tale - The Dwinnex
Insider Sale: President Brian Hole Sells Shares of Willis Lease Finance Corp (WLFC) - Yahoo Finance UK
IMCR’s 52-Week Rollercoaster: From $33.04 to $76.98 – What’s Next for Investors? - The InvestChronicle
Immunocore CFO to depart, company seeks replacement - Investing.com
IMCR’s price-to-free cash flow ratio: How it affects investment decisions - US Post News
Immunocore Holdings plc ADR [IMCR] Insider Activity: An Update for Investors - Knox Daily
Top 10 ADR Stocks To Buy According to Hedge Funds - Insider Monkey
Ratio Examination: Immunocore Holdings plc ADR (IMCR)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Examining the Potential Price Growth of Immunocore Holdings plc ADR (IMCR) - Knox Daily
Cancer Immunotherapy Market Size Expected to Touch USD 530.2 Billion by 2034, With 14.2% CAGR Growth: Prophecy Market Insights - GlobeNewswire Inc.
Potential Price Increase for Immunocore Holdings plc ADR (IMCR) After Recent Insider Activity - Knox Daily
Mizuho backs Outperform rating for Immunocore stock despite PT cut - Investing.com
Earnings call: Immunocore reports robust growth for KIMMTRAK in Q2 - Investing.com India
It would be worthwhile to take a closer look at Immunocore Holdings plc ADR (IMCR) - US Post News
Insider Selling Buzz: Immunocore Holdings plc ADR [IMCR] CHIEF HR OFFICER St Leger Tina Amber sold 4,375 shares of the company – Knox Daily - Knox Daily
An Analysis of Immunocore Holdings plc ADR (IMCR)’s Potential Price Growth - Knox Daily
Trading Day Review: Immunocore Holdings plc ADR (IMCR) Loses Momentum, Closing at 38.87 - The Dwinnex
Prepare Yourself for Liftoff: Immunocore Holdings plc ADR (IMCR) - SETE News
Should investors be concerned about Immunocore Holdings plc ADR (IMCR)? - US Post News
Keeping an Eye on Immunocore Holdings plc ADR (IMCR) After Insider Trading Activity - Knox Daily
Singtel backs amalgamation of Intouch and GULF to simplify AIS’s holding structure - Yahoo Finance
BTO June 2024: Alternative Resale Flats to Consider in the Same Estates - Yahoo Finance
Advanced Melanoma Clinical Trial Pipeline Analysis - GlobeNewswire Inc.
A Look at Immunocore Holdings plc ADR (IMCR) Shares in the Recent Past Indicates Growth - SETE News
Immunocore Holdings plc ADR (IMCR) Becoming More Attractive for Investors - Knox Daily
Immunocore Holdings plc ADR (IMCR) is looking forward to a strong quarter – Sete News - SETE News
Immunocore Holdings plc ADR [IMCR] Revenue clocked in at $266.18 million, down -47.28% YTD: What's Next? – The ... - The DBT News
why Cenovus Energy Inc [CVE] is a Good Choice for Investors After New Price Target of $24.59 – The DBT News - The DBT News
Bitdeer Technologies Holding Co [BTDR] gain 17.75% so far this year. What now? - The DBT News
Market cap of Akoustis Technologies Inc [AKTS] reaches 12.67M – now what? - The DBT News
Insider Sale Alert: Immunocore Holdings plc ADR [IMCR] – Is it Time to sell? – Knox Daily - Knox Daily
Immunocore Holdings plc ADR: Buy, Hold, or Sell? Analysts Weigh In Amid Market Challenges - The InvestChronicle
Li Ning Company Limited (OTCMKTS:LNNGY) Short Interest Down 91.9% in June - Defense World
Immunocore Holdings Plc Adr (IMCR) 財務データ
収益
当期純利益
現金流量
EPS
Immunocore Holdings Plc Adr (IMCR) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| St Leger Tina Amber | CHIEF HR OFFICER |
Apr 01 '24 |
Sale |
64.06 |
4,375 |
280,262 |
0 |
| Berman David M | HEAD OF R&D |
Feb 28 '24 |
Option Exercise |
17.46 |
36,509 |
637,447 |
36,509 |
| Berman David M | HEAD OF R&D |
Feb 28 '24 |
Sale |
68.59 |
36,509 |
2,504,158 |
0 |
| Berman David M | HEAD OF R&D |
Feb 27 '24 |
Option Exercise |
17.46 |
54,938 |
959,217 |
54,938 |
| Berman David M | HEAD OF R&D |
Feb 26 '24 |
Option Exercise |
17.46 |
28,553 |
498,535 |
28,553 |
| Berman David M | HEAD OF R&D |
Feb 27 '24 |
Sale |
70.86 |
54,938 |
3,893,030 |
0 |
| Berman David M | HEAD OF R&D |
Feb 26 '24 |
Sale |
70.65 |
28,553 |
2,017,288 |
0 |
| St Leger Tina Amber | Chief HR Officer |
Jan 03 '24 |
Option Exercise |
29.87 |
4,375 |
130,681 |
4,375 |
| St Leger Tina Amber | Chief HR Officer |
Jan 03 '24 |
Sale |
69.89 |
4,375 |
305,781 |
0 |
2.02%
0.47%
大文字化:
|
ボリューム (24 時間):